Gerhard Frey

1.2k total citations
39 papers, 935 citations indexed

About

Gerhard Frey is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Gerhard Frey has authored 39 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Oncology. Recurrent topics in Gerhard Frey's work include Monoclonal and Polyclonal Antibodies Research (14 papers), RNA and protein synthesis mechanisms (7 papers) and Bacterial Genetics and Biotechnology (6 papers). Gerhard Frey is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), RNA and protein synthesis mechanisms (7 papers) and Bacterial Genetics and Biotechnology (6 papers). Gerhard Frey collaborates with scholars based in Germany, United States and Switzerland. Gerhard Frey's co-authors include Michael Thomm, Winfried Hausner, Dan E. Robertson, Xuqiu Tan, Karl O. Stetter, Toby H. Richardson, Walter Callen, Jay M. Short, Jay M. Short and Carl A. Miller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Gerhard Frey

38 papers receiving 894 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerhard Frey Germany 17 674 196 190 172 159 39 935
Hisashi Yasueda Japan 20 670 1.0× 178 0.9× 108 0.6× 85 0.5× 162 1.0× 49 1.0k
Martin Gamer Germany 13 420 0.6× 189 1.0× 145 0.8× 41 0.2× 50 0.3× 22 591
Bradley R. Kelemen United States 15 577 0.9× 50 0.3× 140 0.7× 78 0.5× 281 1.8× 16 844
Clark Ford United States 23 816 1.2× 70 0.4× 674 3.5× 188 1.1× 267 1.7× 45 1.3k
Xuqiu Tan United States 11 882 1.3× 33 0.2× 270 1.4× 44 0.3× 234 1.5× 11 1.1k
Andreas Knapp Germany 14 414 0.6× 75 0.4× 44 0.2× 73 0.4× 66 0.4× 27 685
Maris Hartmanis Sweden 14 642 1.0× 122 0.6× 66 0.3× 94 0.5× 185 1.2× 15 820
Cinzia Calvio Italy 15 1.2k 1.7× 163 0.8× 125 0.7× 64 0.4× 93 0.6× 41 1.4k
Gilvan Pessoa Furtado Brazil 15 484 0.7× 73 0.4× 183 1.0× 22 0.1× 182 1.1× 28 714
Gerhard Greller Germany 13 414 0.6× 88 0.4× 60 0.3× 85 0.5× 177 1.1× 28 583

Countries citing papers authored by Gerhard Frey

Since Specialization
Citations

This map shows the geographic impact of Gerhard Frey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard Frey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard Frey more than expected).

Fields of papers citing papers by Gerhard Frey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerhard Frey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard Frey. The network helps show where Gerhard Frey may publish in the future.

Co-authorship network of co-authors of Gerhard Frey

This figure shows the co-authorship network connecting the top 25 collaborators of Gerhard Frey. A scholar is included among the top collaborators of Gerhard Frey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerhard Frey. Gerhard Frey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Hwai Wen, Gerhard Frey, Jing Wang, et al.. (2025). Preclinical development of ozuriftamab vedotin (BA3021), a novel ROR2-specific conditionally active biologic antibody–drug conjugate. mAbs. 17(1). 2490078–2490078. 6 indexed citations
2.
3.
Xing, Charles, et al.. (2024). Abstract 744: Novel conditionally active biologic (CAB) tetravalent T-cell engagers targeting solid tumors. Cancer Research. 84(6_Supplement). 744–744. 1 indexed citations
4.
5.
Lucas, Matthew C., Charles Xing, Cathy Chang, et al.. (2023). Abstract 1871: Novel conditionally active bispecific HER2 x CD3 T cell engager targeting solid tumors. Cancer Research. 83(7_Supplement). 1871–1871. 1 indexed citations
6.
Chang, Hwai Wen, Gerhard Frey, Charles Xing, et al.. (2021). Generating tumor-selective conditionally active biologic anti-CTLA4 antibodies via protein-associated chemical switches. Proceedings of the National Academy of Sciences. 118(9). 37 indexed citations
7.
Schoepp, Randal J., Oliver Schröder, Trevin Holland, et al.. (2008). Rapid discovery and optimization of therapeutic antibodies against emerging infectious diseases. Protein Engineering Design and Selection. 21(8). 495–505. 7 indexed citations
8.
Tachikawa, Kiyoshi, Oliver Schröder, Gerhard Frey, Steven P. Briggs, & Takashi Sera. (2004). Regulation of the endogenous VEGF-A gene by exogenous designed regulatory proteins. Proceedings of the National Academy of Sciences. 101(42). 15225–15230. 42 indexed citations
9.
Palackal, Nisha, Walter Callen, Paul Dupree, et al.. (2004). An evolutionary route to xylanase process fitness. Protein Science. 13(2). 494–503. 89 indexed citations
10.
Richardson, Toby H., Xuqiu Tan, Gerhard Frey, et al.. (2004). Discovery of Pectin-degrading Enzymes and Directed Evolution of a Novel Pectate Lyase for Processing Cotton Fabric. Journal of Biological Chemistry. 280(10). 9431–9438. 89 indexed citations
11.
Richardson, Toby H., Xuqiu Tan, Gerhard Frey, et al.. (2002). A Novel, High Performance Enzyme for Starch Liquefaction. Journal of Biological Chemistry. 277(29). 26501–26507. 150 indexed citations
12.
Minuth, Torsten, Matthew C. Henn, Kerstin Rutkat, et al.. (1999). The Recombinant Thermosome from the Hyperthermophilic Archaeon Methanopyrus kandleri: In Vitro Analysis of Its Chaperone Activity. Biological Chemistry. 380(1). 55–62. 13 indexed citations
13.
Minuth, Torsten, Gerhard Frey, Petra Lindner, et al.. (1998). Recombinant homo‐ and hetero‐oligomers of an ultrastable chaperonin from the archaeon Pyrodictium occultum show chaperone activity in vitro. European Journal of Biochemistry. 258(2). 837–845. 21 indexed citations
14.
Dirmeier, Reinhard, Martin Keller, Gerhard Frey, Harald Huber, & Karl O. Stetter. (1998). Purification and properties of an extremely thermostable membrane‐bound sulfur‐reducing complex from the hyperthermophilic Pyrodictium abyssi. European Journal of Biochemistry. 252(3). 486–491. 31 indexed citations
15.
Frey, Gerhard, et al.. (1996). Purification and structural characterization of the thermosome from the hyperthermophilic archaeum Methanopyrus kandleri. FEBS Letters. 379(2). 127–131. 38 indexed citations
16.
Koller, Gabriele, John N. Reeve, Gerhard Frey, & Michael Thomm. (1992). Transcription in vitro and in vivo of the 7S RNA gene associated with the ribosomal RNA operon in the hyperthermophilic archaeonMethanothermus fervidus. FEMS Microbiology Letters. 98(1-3). 95–101. 4 indexed citations
17.
Hausner, Winfried, Gerhard Frey, & Michael Thomm. (1991). Control regions of an archaeal gene. Journal of Molecular Biology. 222(3). 495–508. 106 indexed citations
18.
Frey, Gerhard, et al.. (1990). An archaebacterial cell-free transcription system. The expression of tRNA genes fromMethanococcus vannieliiis mediated by a transcription factor. Nucleic Acids Research. 18(6). 1361–1367. 46 indexed citations
19.
Thomm, Michael, et al.. (1989). An archaebacterial promoter sequence assigned by RNA polymerase binding experiments. Canadian Journal of Microbiology. 35(1). 30–35. 27 indexed citations
20.
Brown, James W., Michael Thomm, Gregory S. Beckler, et al.. (1988). An archaebacterial RNA polymerase binding site and transcription initiation of thehisA gene inMethanococcus vannielii. Nucleic Acids Research. 16(1). 135–150. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hisashi Yasueda Breakdown of academic impact, for papers by Martin Gamer Breakdown of academic impact, for papers by Bradley R. Kelemen Breakdown of academic impact, for papers by Clark Ford Breakdown of academic impact, for papers by Xuqiu Tan Breakdown of academic impact, for papers by Andreas Knapp Breakdown of academic impact, for papers by Maris Hartmanis Breakdown of academic impact, for papers by Cinzia Calvio Breakdown of academic impact, for papers by Gilvan Pessoa Furtado Breakdown of academic impact, for papers by Gerhard Greller
Rankless by CCL
2026